Compumedics Ltd

ASX:CMP (Australia)  
A$ 0.23 (-4.17%) May 20
32.86
P/B:
2.25
Market Cap:
A$ 40.75M ($ 27.17M)
Enterprise V:
A$ 46.30M ($ 30.88M)
Volume:
1.10K
Avg Vol (2M):
17.47K
Also Trade In:
Volume:
1.10K
Avg Vol (2M):
17.47K
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Compumedics Ltd ( ASX:CMP ) from 2000 to May 20 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Compumedics stock (ASX:CMP) PE ratio as of May 20 2024 is 32.86. More Details

Compumedics Ltd (ASX:CMP) PE Ratio (TTM) Chart

To

Compumedics Ltd (ASX:CMP) PE Ratio (TTM) Historical Data

Total 1265
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 15
Compumedics PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-05-21 32.9 2024-03-19 38.6
2024-05-20 32.9 2024-03-18 41.1
2024-05-17 34.3 2024-03-15 40.7
2024-05-16 34.3 2024-03-14 40.7
2024-05-15 33.6 2024-03-13 40.0
2024-05-14 35.7 2024-03-12 40.0
2024-05-13 35.7 2024-03-11 39.3
2024-05-10 35.7 2024-03-08 38.6
2024-05-09 37.1 2024-03-07 38.6
2024-05-08 37.1 2024-03-06 39.3
2024-05-07 37.1 2024-03-05 42.1
2024-05-06 37.1 2024-03-04 47.1
2024-05-03 37.1 2024-03-01 50.0
2024-05-02 35.7 2024-02-29 46.4
2024-05-01 35.7 2024-02-28 46.4
2024-04-30 37.1 2024-02-27 46.4
2024-04-29 37.1 2024-02-26 46.4
2024-04-26 35.7 2024-02-23 46.4
2024-04-25 37.1 2024-02-22 45.7
2024-04-24 37.1 2024-02-21 45.7
2024-04-23 37.1 2024-02-20 45.7
2024-04-22 37.1 2024-02-19 44.3
2024-04-19 38.6 2024-02-16 44.3
2024-04-18 37.9 2024-02-15 45.7
2024-04-17 37.9 2024-02-14 47.1
2024-04-16 37.9 2024-02-13 52.1
2024-04-15 37.9 2024-02-12 55.0
2024-04-12 37.9 2024-02-09 55.0
2024-04-11 37.9 2024-02-08 54.3
2024-04-10 37.9 2024-02-07 55.0
2024-04-09 38.6 2024-02-06 51.4
2024-04-08 40.0 2024-02-05 52.9
2024-04-05 40.0 2024-02-02 54.3
2024-04-04 38.6 2024-02-01 54.3
2024-04-03 38.6 2024-01-31 54.3
2024-04-02 38.6 2024-01-30 55.7
2024-04-01 38.6 2024-01-29 55.7
2024-03-29 38.6 2024-01-26 57.1
2024-03-28 38.6 2024-01-25 57.1
2024-03-27 40.7 2024-01-24 56.4
2024-03-26 40.7 2024-01-23 56.4
2024-03-25 40.0 2024-01-22 55.0
2024-03-22 40.0 2024-01-19 54.3
2024-03-21 38.6 2024-01-18 52.9
2024-03-20 38.6 2024-01-17 55.0

Compumedics Ltd (ASX:CMP) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Compumedics Ltd is a medical device company. It is engaged in the development, manufacture, and commercialisation of diagnostic technologies for sleep, brain and ultrasonic blood-flow monitoring applications. The company is organized into geographical operating segments, being the United States of Americas, Australia and the Asia Pacific, and Europe and the Middle East. It derives a majority of its revenue from Australia and the Asia Pacific region.